62岁的Paul Read在UCL医院的实验放射性治疗中经历了50%的血浆瘤肿瘤减少。 62-year-old Paul Read experiences 50% glioblastoma tumor reduction with experimental radioactive therapy at UCL Hospital.
一名 62 岁的男性 Paul Read 在几周内发现，由于伦敦大学学院医院正在测试一种实验性放射性疗法，他的胶质母细胞瘤肿瘤大小在几周内缩小了 50%。 A 62-year-old man, Paul Read, has seen a 50% reduction in his glioblastoma tumor size within weeks due to an experimental radioactive therapy being tested at University College London Hospitals. 这种治疗旨在直接将低放射性直接注入肿瘤,旨在针对癌症细胞,同时保护健康组织。 This treatment, designed to inject low levels of radioactivity directly into the tumor, aims to target cancer cells while preserving healthy tissue. 由保罗·穆赫兰德博士牵头的这次试验,目的是提高这一剧烈脑癌的存活率。 The trial, led by Dr. Paul Mulholland, seeks to improve survival rates for this aggressive brain cancer.